Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Progyny Inc before investing.

In this article, we go over a few key elements for understanding Progyny Inc’s stock price such as:

• Progyny Inc’s current stock price and volume
• Why Progyny Inc’s stock price changed recently
• Upgrades and downgrades for PGNY from analysts
• PGNY’s stock price momentum as measured by its relative strength

About Progyny Inc (PGNY)

Before we jump into Progyny Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Want to learn more about Progyny Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Progyny Inc.

Progyny Inc’s Stock Price as of Market Close

As of July 18, 2024, 4:00 PM, CST, Progyny Inc’s stock price was $28.02.

Progyny Inc is down 5.27% from its previous closing price of $29.58.

During the last market session, Progyny Inc’s stock traded between $29.52 and $30.42. Currently, there are 96.48 million shares of Progyny Inc stock available for purchase.

Progyny Inc’s price-earnings (P/E) ratio is currently at 48.7, which is high compared to the Managed Health care industry median of 22.4. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Progyny Inc Stock Price History

Progyny Inc’s (PGNY) price is currently down 2.06% so far this month.

During the month of July, Progyny Inc’s stock price has reached a high of $30.42 and a low of $26.98.

Over the last year, Progyny Inc has hit prices as high as $44.95 and as low as $23.90. Year to date, Progyny Inc’s stock is down 10.05%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Progyny Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of July 17, 2024,, no analysts have changed their rating of Progyny Inc’s stock over the last month.

Additionally, you'll want to evaluate Progyny Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Progyny Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Progyny Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Progyny Inc (PGNY) by visiting AAII Stock Evaluator.

Relative Price Strength of Progyny Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 17, 2024, Progyny Inc has a weighted four-quarter relative price strength of -12.92%, which translates to a Momentum Score of 25 and is considered to be Weak.

Want to learn more about how Progyny Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Progyny Inc Stock Price: Bottom Line

As of July 18, 2024, Progyny Inc’s stock price is $28.02, which is down 5.27% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Progyny Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.